Description
QINLOCK is a prescription medicine used to treat adults with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitor medicines, including imatinib, for their GIST.
QINLOCK (pronounced “kin-lok”) is a prescription medicine used to treat adults with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitor medicines, including imatinib, for their GIST.
QINLOCK is also:
- A type of targeted medicine
- A different kind of tyrosine kinase inhibitor (TKI) treatment
- Not a chemotherapy
QINLOCK targets
2 outlets, or 2 key sites, of tyrosine kinases involved in GIST.
By targeting these 2 outlets, QINLOCK limits the tyrosine kinase’s ability to power GIST cancer cells to grow and spread.
Since mutations can happen on different outlets, targeting 2 outlets helps QINLOCK target a range of mutations.
GISTs are tumors that show up in the GI (gastrointestinal) tract, often in the stomach or small intestine. About 4,000-6,000 adults in the US are diagnosed with GIST every year.
The cause of GIST is unknown. There are no known lifestyle factors that cause GIST (such as diet or smoking).
Download for details: QINLOCK
